Download Poster (21.6 MB)

Program Affiliation

University Outreach - University of Notre Dame


PARP inhibitor resistance, PARP inhibitor, ATR inhibitor, Type 1 Interferon response

Use of ATR-PARP inhibitor combination therapy to treat and generate an immune response in PARP inhibitor resistant breast cancer is questioned



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.